Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07516496) titled 'Metabolic Phenotyping in vEDS' on April 1.

Study Type: Observational [Patient Registry]

Primary Sponsor: Cambridge University Hospitals NHS Foundation Trust

Condition: Vascular Ehlers-Danlos Syndrome Vascular Ehlers Danlos Syndrome Vascular EDS (vEDS)

Intervention: Other: No intervention, observational

Recruitment Status: Recruiting

Date of First Enrollment: March 5, 2026

Target Sample Size: 15

Countries of Recruitment: United Kingdom

To know more, visit https://clinicaltrials.gov/study/NCT07516496

Disclaimer: Curated by HT Syndication....